Minomic International specialises in the development of diagnostics for cancers such as prostate, bladder and pancreatic. In 2008, Minomic was subject to a takeover bid by Probiomics but the transaction did not go through.
Minomic International
Follow
Get notifications in MyBN when activity occurs.